tiprankstipranks
Trending News
More News >
KRM22 Plc (GB:KRM)
LSE:KRM
Advertisement

KRM22 (KRM) AI Stock Analysis

Compare
2 Followers

Top Page

GB:KRM

KRM22

(LSE:KRM)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 4o)
Rating:45Neutral
Price Target:
41.00p
▲(2.50% Upside)
The overall stock score is primarily impacted by significant financial challenges, including ongoing net losses and high leverage, which pose risks to financial stability. Technical analysis shows mixed signals with short-term positive momentum but potential medium-term resistance. Valuation is poor due to negative earnings and lack of dividends, further impacting the score.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for KRM22's risk management solutions, suggesting a robust market position and potential for future expansion.
Cash Flow Management
Positive operating cash flow reflects effective cash management, providing the company with the liquidity needed to invest in growth and manage obligations.
Gross Profit Margin
A strong gross profit margin suggests effective cost control in production, which can support long-term profitability as the company scales.
Negative Factors
Net Losses
Ongoing net losses highlight challenges in achieving profitability, which could hinder long-term sustainability and investor confidence.
High Leverage
High leverage increases financial risk, limiting flexibility and potentially impacting the company's ability to invest in growth opportunities.
Negative Equity Ratio
A negative equity ratio indicates financial instability, posing a risk of insolvency if not addressed, which could affect long-term operations.

KRM22 (KRM) vs. iShares MSCI United Kingdom ETF (EWC)

KRM22 Business Overview & Revenue Model

Company DescriptionKRM22 (KRM) is a technology company specializing in risk management solutions for the financial services sector. The company focuses on providing advanced data analytics, risk assessment tools, and compliance software designed to help clients navigate complex regulatory environments and manage operational risks effectively. KRM's core products include a robust risk management platform that integrates data from various sources, offering real-time insights and analytics to enhance decision-making processes for financial institutions.
How the Company Makes MoneyKRM22 generates revenue primarily through subscription-based models for its risk management software and analytics tools. Clients pay recurring fees for access to the platform, which can vary based on the tier of service and the scale of usage. Additionally, KRM may earn revenue from consulting services related to the implementation of its software solutions and ongoing support. Strategic partnerships with financial institutions and regulatory bodies enhance its offerings and contribute to its revenue by expanding its market reach and credibility. The company's ability to innovate and adapt its solutions to meet evolving regulatory demands also plays a crucial role in attracting and retaining clients.

KRM22 Financial Statement Overview

Summary
KRM22 faces significant financial challenges with ongoing net losses and high leverage, risking financial stability. Despite revenue growth, profitability remains elusive due to high costs. Positive cash flow from operations is a bright spot, yet overall cash management needs improvement. Immediate actions to improve profitability and reduce leverage are essential for long-term viability.
Income Statement
35
Negative
The company has shown a positive revenue growth trajectory with revenue increasing from the previous year. However, it continues to operate at a net loss, with negative net profit and EBIT margins. The gross profit margin is strong, indicating efficiency in managing production costs, but the negative EBITDA and EBIT margins suggest challenges in overall cost management and profitability.
Balance Sheet
25
Negative
The balance sheet shows a concerning debt-to-equity ratio due to negative stockholders' equity, indicating high leverage and financial instability. The equity ratio is negative, highlighting the company's liabilities exceed its assets. This presents a risk of insolvency if not addressed. Total assets have decreased, further stressing financial health.
Cash Flow
45
Neutral
Positive operating cash flow indicates improved cash management, yet the free cash flow remains low due to significant capital expenditures. The free cash flow growth rate shows improvement from the previous year, but the ratio of operating cash flow to net income indicates inefficiencies in converting income to cash, given the consistent net losses.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.12M6.77M5.27M4.27M4.13M4.59M
Gross Profit5.70M5.60M4.12M3.32M3.45M4.15M
EBITDA-497.83K350.00K-3.22M-989.00K-1.29M-3.72M
Net Income-1.65M-1.29M-4.62M-3.10M-3.33M-5.88M
Balance Sheet
Total Assets8.13M7.40M7.81M11.15M14.20M12.59M
Cash, Cash Equivalents and Short-Term Investments1.36M1.03M886.00K1.90M5.36M1.97M
Total Debt5.31M5.06M4.65M3.59M3.66M3.77M
Total Liabilities10.33M9.63M8.91M7.97M7.49M7.64M
Stockholders Equity-2.20M-2.23M-1.10M3.18M6.71M4.95M
Cash Flow
Free Cash Flow1.80M268.00K-2.00M-2.97M-802.00K-1.90M
Operating Cash Flow1.80M1.42M-879.00K-2.12M-47.00K-942.00K
Investing Cash Flow-1.06M-1.16M-1.16M-848.00K-755.00K-961.00K
Financing Cash Flow-3.00K-122.00K1.04M-535.00K4.19M2.84M

KRM22 Technical Analysis

Technical Analysis Sentiment
Negative
Last Price40.00
Price Trends
50DMA
42.41
Negative
100DMA
42.13
Negative
200DMA
35.79
Positive
Market Momentum
MACD
-0.78
Positive
RSI
24.81
Positive
STOCH
41.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:KRM, the sentiment is Negative. The current price of 40 is below the 20-day moving average (MA) of 42.65, below the 50-day MA of 42.41, and above the 200-day MA of 35.79, indicating a neutral trend. The MACD of -0.78 indicates Positive momentum. The RSI at 24.81 is Positive, neither overbought nor oversold. The STOCH value of 41.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:KRM.

KRM22 Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
63
Neutral
-82.05-0.97%-87.43%-107.41%
49
Neutral
£5.66M-12.64%-0.73%-790.70%
45
Neutral
$15.91M-9.6115.59%54.47%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:KRM
KRM22
40.00
11.50
40.35%
GB:INV
The Investment
64.00
-11.20
-14.89%
GB:WCW
Walker Crips
13.25
-4.75
-26.39%
GB:ZOYO
Honye Financial Services Ltd
25.00
-20.00
-44.44%
GB:CGO
Contango Holdings Plc
0.80
-0.50
-38.46%
GB:450
Marwyn Acquisition Company PLC
2.10
0.00
0.00%

KRM22 Corporate Events

Private Placements and FinancingShareholder Meetings
KRM22 Raises £9.2 Million to Enhance Risk Management Focus
Positive
Oct 15, 2025

KRM22 has successfully raised approximately £9.2 million through a placing and subscription of shares at a slight discount to market price. The funds will support the company’s focus on risk management in capital markets. A General Meeting is scheduled for shareholder approval, with the new shares expected to commence trading on AIM in early November. Major shareholders, Kestrel Investment Partners and Canaccord Genuity, participated in the fundraising, highlighting confidence in KRM22’s strategic direction.

The most recent analyst rating on (GB:KRM) stock is a Hold with a £40.00 price target. To see the full list of analyst forecasts on KRM22 stock, see the GB:KRM Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
KRM22 Announces £9.2 Million Fundraising to Expand Risk Management Solutions
Positive
Oct 14, 2025

KRM22 plc has announced a proposed placing and subscription to raise £9.2 million by issuing new ordinary shares at 40 pence each. The funds will be used to expand its risk management applications beyond the ETD space, repay a £5.7 million debt facility with Trading Technologies, and support sales and marketing efforts to boost Annual Recurring Revenue (ARR). The company has shown growth in ARR and revenue in the first half of 2025, indicating a positive trajectory in its financial performance. The fundraising is expected to enhance KRM22’s market positioning by broadening its multi-asset risk management solutions, benefiting stakeholders through increased operational capabilities and financial flexibility.

The most recent analyst rating on (GB:KRM) stock is a Hold with a £40.00 price target. To see the full list of analyst forecasts on KRM22 stock, see the GB:KRM Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
KRM22 Reports Strong Growth in H1 2025 with Increased ARR and Revenue
Positive
Sep 17, 2025

KRM22 plc announced its unaudited interim results for the first half of 2025, reporting a 20% growth in Annualised Recurring Revenue (ARR) to £7.2 million and a 10.6% increase in total revenue to £3.6 million. The company achieved an adjusted EBITDA profit of £0.4 million, despite a pre-tax loss of £1.6 million. The growth was driven by strong demand for its Risk Manager and Limits Manager applications, with significant cross-selling to existing clients. KRM22’s strategic focus on integrating these applications has been validated by the increased adoption among Futures Commissions Merchants. The company’s proactive response to market volatility and disciplined cost control have positioned it for continued growth and profitability.

The most recent analyst rating on (GB:KRM) stock is a Hold with a £44.00 price target. To see the full list of analyst forecasts on KRM22 stock, see the GB:KRM Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
KRM22 Reports Strong First Half 2025 Performance with Increased ARR
Positive
Aug 7, 2025

KRM22 plc has reported a positive trading update for the first half of 2025, with an increase in Annual Recurring Revenue (ARR) from £6.6m to £7.2m, driven by cross-sales and price increases. Despite some customer churn, the company maintains a strong sales pipeline and expects to meet market expectations by year-end. The cash balance improved to £1.4m, and KRM22 continues to focus on careful cash management while aiming to become a cash-generative and profitable business.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 17, 2025